SLC2A3 and Alzheimer disease: Alterations in brain glucose concentration in AD may be explained by the low protein levels of GLUT3, a neuronal glucose transporter, which are associated with increased neuritic plaque and neurofibrillary tangle pathology, possibly during the early stages of AD development [550,551,552].